Free Trial
NASDAQ:TNDM

Tandem Diabetes Care (TNDM) Stock Price, News & Analysis

Tandem Diabetes Care logo
$17.06 -0.02 (-0.09%)
Closing price 03:58 PM Eastern
Extended Trading
$16.72 -0.34 (-2.02%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tandem Diabetes Care Stock (NASDAQ:TNDM)

Key Stats

Today's Range
$16.60
$17.29
50-Day Range
$16.77
$23.52
52-Week Range
$15.75
$48.24
Volume
1.10 million shs
Average Volume
1.48 million shs
Market Capitalization
$1.14 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.43
Consensus Rating
Hold

Company Overview

Tandem Diabetes Care Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
86th Percentile Overall Score

TNDM MarketRank™: 

Tandem Diabetes Care scored higher than 86% of companies evaluated by MarketBeat, and ranked 176th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tandem Diabetes Care has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 6 buy ratings, 9 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tandem Diabetes Care has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Tandem Diabetes Care's stock forecast and price target.
  • Earnings Growth

    Earnings for Tandem Diabetes Care are expected to grow in the coming year, from ($1.68) to ($1.20) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tandem Diabetes Care is -6.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tandem Diabetes Care is -6.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tandem Diabetes Care has a P/B Ratio of 4.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Tandem Diabetes Care's valuation and earnings.
  • Percentage of Shares Shorted

    13.50% of the float of Tandem Diabetes Care has been sold short.
  • Short Interest Ratio / Days to Cover

    Tandem Diabetes Care has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Tandem Diabetes Care has recently increased by 12.64%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Tandem Diabetes Care does not currently pay a dividend.

  • Dividend Growth

    Tandem Diabetes Care does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.50% of the float of Tandem Diabetes Care has been sold short.
  • Short Interest Ratio / Days to Cover

    Tandem Diabetes Care has a short interest ratio ("days to cover") of 5.9.
  • Change versus previous month

    Short interest in Tandem Diabetes Care has recently increased by 12.64%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Tandem Diabetes Care has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Tandem Diabetes Care this week, compared to 7 articles on an average week.
  • Search Interest

    Only 2 people have searched for TNDM on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Tandem Diabetes Care to their MarketBeat watchlist in the last 30 days.
Receive TNDM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter.

TNDM Stock News Headlines

RSI Alert: Tandem Diabetes Care (TNDM) Now Oversold
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
TNDM - Tandem Diabetes Care Inc Key Metrics - Morningstar
See More Headlines

TNDM Stock Analysis - Frequently Asked Questions

Tandem Diabetes Care's stock was trading at $36.02 at the beginning of the year. Since then, TNDM stock has decreased by 52.6% and is now trading at $17.0640.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) announced its quarterly earnings data on Wednesday, April, 30th. The medical device company reported ($0.67) earnings per share for the quarter, missing the consensus estimate of ($0.60) by $0.07. The firm's revenue for the quarter was up 22.3% on a year-over-year basis.
Read the conference call transcript
.

Shares of Tandem Diabetes Care reverse split on the morning of Tuesday, October 10th 2017.The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tandem Diabetes Care investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), PayPal (PYPL), Alibaba Group (BABA) and Netflix (NFLX).

Company Calendar

Last Earnings
4/30/2025
Today
7/03/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:TNDM
Fax
N/A
Employees
2,650
Year Founded
2006

Price Target and Rating

Average Stock Price Target
$33.43
High Stock Price Target
$59.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+97.9%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
15 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$96.03 million
Pretax Margin
-17.75%

Debt

Sales & Book Value

Annual Sales
$940.20 million
Price / Cash Flow
N/A
Book Value
$4.01 per share
Price / Book
4.21

Miscellaneous

Free Float
65,341,000
Market Cap
$1.13 billion
Optionable
Optionable
Beta
1.48

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:TNDM) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners